Over the past 90 days, insider trading at Silexion Therapeutics Corp has shown a net sell-off of $31,032.48, primarily driven by a single transaction. CSO and CDO Shirvan Mitchell sold 22,818 shares on March 26, 2026. This activity occurred against a backdrop of significant stock price decline over the last three months.
